首页 | 本学科首页   官方微博 | 高级检索  
     

以前列腺干细胞抗原为靶点的前列腺癌免疫治疗研究进展
引用本文:董磊,张晓鹏,于长明,陈薇. 以前列腺干细胞抗原为靶点的前列腺癌免疫治疗研究进展[J]. 生物技术通讯, 2012, 23(2): 291-293
作者姓名:董磊  张晓鹏  于长明  陈薇
作者单位:1. 空军总医院临床检验中心,北京,100142
2. 军事医学科学院微生物流行病研究所,病原微生物生物安全国家重点实验室 北京,100071
3. 军事医学科学院生物工程研究所 北京100071
摘    要:前列腺干细胞抗原(PSCA)为细胞膜表面抗原,在正常前列腺组织中低表达,在雄激素依赖性和非依赖性前列腺癌组织中高表达,有较高的组织特异性,是前列腺癌治疗的理想靶标,近年来以PSCA为靶点的前列腺癌治疗性疫苗的研究已成为热点。我们简要综述以PSCA为靶点治疗前列腺癌的研究进展。

关 键 词:前列腺干细胞抗原  前列腺癌  免疫治疗

Research of Immunotherapy for Prostate Cancer Based on Prostate Stem Cell Antigen
DONG Lei , ZHANG Xiao-Peng , YU Chang-Ming , CHEN Wei. Research of Immunotherapy for Prostate Cancer Based on Prostate Stem Cell Antigen[J]. Letters in Biotechnology, 2012, 23(2): 291-293
Authors:DONG Lei    ZHANG Xiao-Peng    YU Chang-Ming    CHEN Wei
Affiliation:1. Clinical Laboratory Center, General Hospital of PLA Air Force, Beijing 100142; 2. State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071; 3. Beijing Institute of Biotechnology, Beijing 100071; China)
Abstract:Prostate stem cell antigen(PSCA) is a surface glycoprotein, which is low-expressing in normal prostate and high-expressing in prostate cancer, bladder cancer and pancreatic cancer with higher tissue specificity. As a ideal target of treating prostate cancer, researches of therapeutic vaccine for prostate cancer based on PSCA have became warm spots. This paper presented a review of research progress on therapy of prostate cancer.
Keywords:prostate stem cell antigen prostate cancer immunotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号